| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1965473 | Clinica Chimica Acta | 2014 | 7 Pages |
Abstract
A significant reduction in AFP-L3 in patients with advanced HCC is an important predictor of survival. Achieving an AFP-L3 response should be one of the therapeutic intents of TACE.
Keywords
phosphate buffered saline Tween-20Concanavalin APBSTTACEDCRAFP-L3transcatheter arterial chemoembolizationHCCα-fetoproteinLens culinaris agglutininLCACon Astable diseaseprogressive diseaseAFPTime-resolved immunofluorometric assayradiologic imagingCoefficient of VariationLBADisease control ratePartial responsecomplete responseHepatocellular carcinoma
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Chen Huang, Shile Sheng, Xiaoguang Sun, Jianju Liu, Gang Huang,